Literature DB >> 25430504

High-risk age window for mortality in children with cystic fibrosis after lung transplantation.

Don Hayes1, Karen S McCoy, Bryan A Whitson, Heidi M Mansour, Joseph D Tobias.   

Abstract

LTx in children with CF remains controversial. The UNOS database was queried from 1987 to 2013 for CF patients <18 yr of age at time of transplant. PCHR model was used to quantify hazard of mortality. 489 recipients were included in the survival analysis. The hazard function of post-transplant mortality was plotted over attained age to identify age window of highest risk, which was 16-20 yr. Unadjusted PCHR model revealed ages immediately after the high-risk window were characterized by lower hazard of mortality (HR = 0.472; 95% CI = 0.302, 0.738; p = 0.001). After adjusting for potential confounders, the decline in mortality hazard immediately after the high-risk window remained statistically significant (HR = 0.394; 95% CI: 0.211, 0.737; p = 0.004). Hazard of mortality in children with CF after LTx was highest between 16 and 20 yr of attained age and declined thereafter.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  age; allograft failure; cystic fibrosis; lung transplantation; survival

Mesh:

Year:  2014        PMID: 25430504     DOI: 10.1111/petr.12401

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  5 in total

1.  Lung Transplantation in Cystic Fibrosis: Trends and Controversies.

Authors:  Joshua Blatter; Stuart Sweet
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-12-01       Impact factor: 1.349

Review 2.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 3.  Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis.

Authors:  Pamela Burcham; Lisa Sarzynski; Sabrina Khalfoun; Kimberly J Novak; Julie C Miller; Dmitry Tumin; Don Hayes
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

4.  Current State of Pediatric Lung Transplantation.

Authors:  Don Hayes; Christian Benden; Stuart C Sweet; Carol K Conrad
Journal:  Lung       Date:  2015-08-04       Impact factor: 2.584

5.  Lung Transplant Index: A Quality Improvement Initiative.

Authors:  Don Hayes; Bob Feeney; Donna J O'Connor; Kerri L Nicholson; Ashley E Nance; Kelly K Sakellaris; Nicole R Dempster; Jaclyn D Groh; Stephen E Kirkby
Journal:  Pediatr Qual Saf       Date:  2019-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.